Related references
Note: Only part of the references are listed.Multiple APOBEC3 Restriction Factors for HIV-1 and One Vif to Rule Them All
Belete A. Desimmie et al.
JOURNAL OF MOLECULAR BIOLOGY (2014)
APOBEC3 Inhibition of Mouse Mammary Tumor Virus Infection: the Role of Cytidine Deamination versus Inhibition of Reverse Transcription
Alyssa L. MacMillan et al.
JOURNAL OF VIROLOGY (2013)
Murine leukemia virus glycosylated Gag blocks apolipoprotein B editing complex 3 and cytosolic sensor access to the reverse transcription complex
Spyridon Stavrou et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
HIV Restriction by APOBEC3 in Humanized Mice
John F. Krisko et al.
PLOS PATHOGENS (2013)
APOBEC3A, APOBEC3B, and APOBEC3H Haplotype 2 Restrict Human T-Lymphotropic Virus Type 1
Marcel Ooms et al.
JOURNAL OF VIROLOGY (2012)
The Cellular Antiviral Protein APOBEC3G Interacts with HIV-1 Reverse Transcriptase and Inhibits Its Function during Viral Replication
Xiaoxia Wang et al.
JOURNAL OF VIROLOGY (2012)
Studies on the Restriction of Murine Leukemia Viruses by Mouse APOBEC3
Silvia Sanchez-Martinez et al.
PLOS ONE (2012)
Host restriction factors in retroviral infection: promises in virus-host interaction
Yong-Hui Zheng et al.
RETROVIROLOGY (2012)
Evolutionary conflicts between viruses and restriction factors shape immunity
Nisha K. Duggal et al.
NATURE REVIEWS IMMUNOLOGY (2012)
Loci Polymorphisms of the APOBEC3G Gene in HIV Type 1-Infected Brazilians
Maria Clara Bizinoto et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2011)
Repression of porcine endogenous retrovirus infection by human APOBEC3 proteins
Jungeun Lee et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2011)
APOBEC3A can activate the DNA damage response and cause cell-cycle arrest
Sebastien Landry et al.
EMBO REPORTS (2011)
Target Cell-Mediated Editing of HIV-1 cDNA by APOBEC3 Proteins in Human Macrophages
Fransje A. Koning et al.
JOURNAL OF VIROLOGY (2011)
Genetic Editing of Herpes Simplex Virus 1 and Epstein-Barr Herpesvirus Genomes by Human APOBEC3 Cytidine Deaminases in Culture and In Vivo
Rodolphe Suspene et al.
JOURNAL OF VIROLOGY (2011)
Somatic hypermutation of human mitochondrial and nuclear DNA by APOBEC3 cytidine deaminases, a pathway for DNA catabolism
Rodolphe Suspene et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
APOBEC3A Is a Specific Inhibitor of the Early Phases of HIV-1 Infection in Myeloid Cells
Gregory Berger et al.
PLOS PATHOGENS (2011)
APOBEC3G expression is dysregulated in primary HIV-1 infection and polymorphic variants influence CD4+ T-cell counts and plasma viral load
Kavidha Reddy et al.
AIDS (2010)
APOBEC3 Proteins Expressed in Mammary Epithelial Cells Are Packaged into Retroviruses and Can Restrict Transmission of Milk-Borne Virions
Chioma M. Okeoma et al.
CELL HOST & MICROBE (2010)
Innate Immune Signaling Induces High Levels of TC-specific Deaminase Activity in Primary Monocyte-derived Cells through Expression of APOBEC3A Isoforms
Beth K. Thielen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Susceptibility of xenotropic murine leukemia virus-related virus (XMRV) to retroviral restriction factors
Harriet C. T. Groom et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Expression of Murine APOBEC3 Alleles in Different Mouse Strains and Their Effect on Mouse Mammary Tumor Virus Infection
Chioma M. Okeoma et al.
JOURNAL OF VIROLOGY (2009)
The AKV Murine Leukemia Virus Is Restricted and Hypermutated by Mouse APOBEC3
Marc-Andre Langlois et al.
JOURNAL OF VIROLOGY (2009)
Induction of APOBEC3 In Vivo Causes Increased Restriction of Retrovirus Infection
Chioma M. Okeoma et al.
JOURNAL OF VIROLOGY (2009)
Enhanced replication and pathogenesis of Moloney murine leukemia virus in mice defective in the murine APOBEC3 gene
Audrey Low et al.
VIROLOGY (2009)
Deaminase-Independent Inhibition of Parvoviruses by the APOBEC3A Cytidine Deaminase
Inigo Narvaiza et al.
PLOS PATHOGENS (2009)
APOBEC3-independent interferon-induced viral clearance in hepatitis B virus transgenic mice
Priscilla Turelli et al.
JOURNAL OF VIROLOGY (2008)
Interactions of murine APOBEC3 and human APOBEC3G with murine leukemia viruses
Samuel J. Rulli et al.
JOURNAL OF VIROLOGY (2008)
Mouse APOBEC3 Restricts Friend Leukemia Virus Infection and Pathogenesis In Vivo
Eri Takeda et al.
JOURNAL OF VIROLOGY (2008)
Evidence for editing of human papillomavirus DNA by APOBEC3 in benign and precancerous lesions
Jean-Pierre Vartanian et al.
SCIENCE (2008)
Apobec3 encodes Rfv3, a gene influencing neutralizing antibody control of retrovirus infection
Mario L. Santiago et al.
SCIENCE (2008)
APOBEC3G Inhibits Elongation of HIV-1 Reverse Transcripts
Kate N. Bishop et al.
PLOS PATHOGENS (2008)
Species-specific restriction of Apobec3-mediated hypermutation
Edward P. Browne et al.
JOURNAL OF VIROLOGY (2008)
Vpr.A3A chimera inhibits HIV replication
Renato S. Aguiar et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Friend retrovirus infection of myeloid dendritic cells impairs maturation, prolongs contact to naive T cells, and favors expansion of regulatory T cells
Sandra Balkow et al.
BLOOD (2007)
Deaminase-independent inhibition of HIV-1 reverse transcription by APOBEC3G
Yasumasa Iwatani et al.
NUCLEIC ACIDS RESEARCH (2007)
The Restriction of Zoonotic PERV Transmission by Human APOBEC3G
Stefan R. Jonsson et al.
PLOS ONE (2007)
Targeting APOBEC3A to the viral nucleoprotein complex confers antiviral activity
Ritu Goila-Gaur et al.
RETROVIROLOGY (2007)
Myeloid differentiation and susceptibility to HIV-1 are linked to APOBEC3 expression
Gang Peng et al.
BLOOD (2007)
Diminished potential for B-lymphoid differentiation after murine leukemia virus infection in vivo and in EML hematopoietic progenitor cells
Samantha L. Finstad et al.
JOURNAL OF VIROLOGY (2007)
Deamination-independent inhibition of hepatitis B virus reverse transcription by APOBEC3G
David H. Nguyen et al.
JOURNAL OF VIROLOGY (2007)
Critical role of dendritic cells in mouse mammary tumor virus in vivo infection
Maria Cecilia Courreges et al.
JOURNAL OF VIROLOGY (2007)
APOBEC3 inhibits mouse mammary tumour virus replication in vivo
Chioma M. Okeoma et al.
NATURE (2007)
APOBEC3F can inhibit the accumulation of HIV-1 reverse transcription products in the absence of hypermutation - Comparisons with APOBEC3G
Rebecca K. Holmes et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Antiviral potency of APOBEC proteins does not correlate with cytidine deamination
Kate N. Bishop et al.
JOURNAL OF VIROLOGY (2006)
APOBEC3 proteins inhibit human LINE-1 retrotransposition
Heide Muckenfuss et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
APOBEC3A is a potent inhibitor of adeno-associated virus and retrotransposons
H Chen et al.
CURRENT BIOLOGY (2006)
Role and mechanism of action of the APOBEC3 family of antiretroviral resistance factors
BR Cullen
JOURNAL OF VIROLOGY (2006)
APOBEC3A and APOBEC3B are potent inhibitors of LTR-retrotransposon function in human cells
HP Bogerd et al.
NUCLEIC ACIDS RESEARCH (2006)
Interferon-inducible expression of APOBEC3 editing enzymes in human hepatocytes and inhibition of hepatitis B virus replication
Marianne Bonvin et al.
HEPATOLOGY (2006)
Development of 2A peptide-based strategies in the design of multicistronic vectors
AL Szymczak et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2005)
Antiviral function of APOBEC3G can be dissociated from cytidine deaminase activity
ENC Newman et al.
CURRENT BIOLOGY (2005)
Functional analysis of vif protein shows less restriction of human immunodeficiency virus type 2 by APOBEC3G
AC Ribeiro et al.
JOURNAL OF VIROLOGY (2005)
Comparison of the differential context-dependence of DNA deamination by APOBEC enzymes:: Correlation with mutation spectra in vivo
RCL Beale et al.
JOURNAL OF MOLECULAR BIOLOGY (2004)
Inhibition of hepatitis B virus replication by APOBEC3G
P Turelli et al.
SCIENCE (2004)
A single amino acid of APOBEC3G controls its species-specific interaction with virion infectivity factor (Vif)
R Schröfelbauer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
APOBEC3G genetic variants and their influence on the progression to AIDS
P An et al.
JOURNAL OF VIROLOGY (2004)
Cytidine deamination of retroviral DNA by diverse APOBEC proteins
KN Bishop et al.
CURRENT BIOLOGY (2004)
APOBEC3G targets specific virus species
M Kobayashi et al.
JOURNAL OF VIROLOGY (2004)
APOBEC-mediated editing of viral RNA
KN Bishop et al.
SCIENCE (2004)
A second human antiretroviral factor, APOBEC3F, is suppressed by the HIV-1 and HIV-2 Vif proteins
HL Wiegand et al.
EMBO JOURNAL (2004)
HIV-1 Vif blocks the antiviral activity of APOBEC3G by impairing both its translation and intracellular stability
K Stopak et al.
MOLECULAR CELL (2003)
Species-specific exclusion of APOBEC3G from HIV-1 virions by Vif
R Mariani et al.
CELL (2003)
Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts
B Mangeat et al.
NATURE (2003)
DNA determination mediates innate immunity to retroviral infection
RS Harris et al.
CELL (2003)
Crystal structure of yeast cytosine deaminase - Insights into enzyme mechanism and evolution
TP Ko et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif
AM Sheehy et al.
NATURE MEDICINE (2003)
Murine retroviruses activate B cells via interaction with toll-like receptor 4
JC Rassa et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Disruption of hematopoiesis and thymopoiesis in the early premalignant stages of infection with SL3-3 murine leukemia virus
K Rulli et al.
JOURNAL OF VIROLOGY (2002)
Share Paper
